A Boosted Ensemble Algorithm for Determination of Plaque Stability in High-Risk Patients on Coronary CTA.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
10 2020
Historique:
received: 14 02 2020
revised: 24 03 2020
accepted: 31 03 2020
pubmed: 20 7 2020
medline: 12 8 2021
entrez: 20 7 2020
Statut: ppublish

Résumé

This study sought to identify culprit lesion (CL) precursors among acute coronary syndrome (ACS) patients based on qualitative and quantitative computed tomography-based plaque characteristics. Coronary computed tomography angiography (CTA) has been validated for patient-level prediction of ACS. However, the applicability of coronary CTA to CL assessment is not known. Utilizing the ICONIC (Incident COroNary Syndromes Identified by Computed Tomography) study, a nested case-control study of 468 patients with baseline coronary CTA, the study included ACS patients with invasive coronary angiography-adjudicated CLs that could be aligned to CL precursors on baseline coronary CTA. Separate blinded core laboratories adjudicated CLs and performed atherosclerotic plaque evaluation. Thereafter, the study used a boosted ensemble algorithm (XGBoost) to develop a predictive model of CLs. Data were randomly split into a training set (80%) and a test set (20%). The area under the receiver-operating characteristic curve of this model was compared with that of diameter stenosis (model 1), high-risk plaque features (model 2), and lesion-level features of CL precursors from the ICONIC study (model 3). Thereafter, the machine learning (ML) model was applied to 234 non-ACS patients with 864 lesions to determine model performance for CL exclusion. CL precursors were identified by both coronary angiography and baseline coronary CTA in 124 of 234 (53.0%) patients, with a total of 582 lesions (containing 124 CLs) included in the analysis. The ML model demonstrated significantly higher area under the receiver-operating characteristic curve for discriminating CL precursors (0.774; 95% confidence interval [CI]: 0.758 to 0.790) compared with model 1 (0.599; 95% CI: 0.599 to 0.599; p < 0.01), model 2 (0.532; 95% CI: 0.501 to 0.563; p < 0.01), and model 3 (0.672; 95% CI: 0.662 to 0.682; p < 0.01). When applied to the non-ACS cohort, the ML model had a specificity of 89.3% for excluding CLs. In a high-risk cohort, a boosted ensemble algorithm can be used to predict CL from non-CL precursors on coronary CTA.

Sections du résumé

OBJECTIVES
This study sought to identify culprit lesion (CL) precursors among acute coronary syndrome (ACS) patients based on qualitative and quantitative computed tomography-based plaque characteristics.
BACKGROUND
Coronary computed tomography angiography (CTA) has been validated for patient-level prediction of ACS. However, the applicability of coronary CTA to CL assessment is not known.
METHODS
Utilizing the ICONIC (Incident COroNary Syndromes Identified by Computed Tomography) study, a nested case-control study of 468 patients with baseline coronary CTA, the study included ACS patients with invasive coronary angiography-adjudicated CLs that could be aligned to CL precursors on baseline coronary CTA. Separate blinded core laboratories adjudicated CLs and performed atherosclerotic plaque evaluation. Thereafter, the study used a boosted ensemble algorithm (XGBoost) to develop a predictive model of CLs. Data were randomly split into a training set (80%) and a test set (20%). The area under the receiver-operating characteristic curve of this model was compared with that of diameter stenosis (model 1), high-risk plaque features (model 2), and lesion-level features of CL precursors from the ICONIC study (model 3). Thereafter, the machine learning (ML) model was applied to 234 non-ACS patients with 864 lesions to determine model performance for CL exclusion.
RESULTS
CL precursors were identified by both coronary angiography and baseline coronary CTA in 124 of 234 (53.0%) patients, with a total of 582 lesions (containing 124 CLs) included in the analysis. The ML model demonstrated significantly higher area under the receiver-operating characteristic curve for discriminating CL precursors (0.774; 95% confidence interval [CI]: 0.758 to 0.790) compared with model 1 (0.599; 95% CI: 0.599 to 0.599; p < 0.01), model 2 (0.532; 95% CI: 0.501 to 0.563; p < 0.01), and model 3 (0.672; 95% CI: 0.662 to 0.682; p < 0.01). When applied to the non-ACS cohort, the ML model had a specificity of 89.3% for excluding CLs.
CONCLUSIONS
In a high-risk cohort, a boosted ensemble algorithm can be used to predict CL from non-CL precursors on coronary CTA.

Identifiants

pubmed: 32682719
pii: S1936-878X(20)30423-X
doi: 10.1016/j.jcmg.2020.03.025
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2162-2173

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Subhi J Al'Aref (SJ)

Division of Cardiology, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas. Electronic address: SJAlaref@UAMS.edu.

Gurpreet Singh (G)

GlaxoSmithKline, Brentford, United Kingdom.

Jeong W Choi (JW)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Zhuoran Xu (Z)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Gabriel Maliakal (G)

Cleerly Health, New York, New York.

Alexander R van Rosendael (AR)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Benjamin C Lee (BC)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Zahra Fatima (Z)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Daniele Andreini (D)

Centro Cardiologico Monzino, Institute for Research Hospitalization, and Health Care, Milan, Italy.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Filippo Cademartiri (F)

Cardiovascular Imaging Center, Institute of Diagnostic and Nuclear Development, Institute for Research Hospitalization, and Health Care, Naples, Italy.

Kavitha Chinnaiyan (K)

Department of Cardiology, William Beaumont Hospital, Royal Oak, Michigan.

Benjamin J W Chow (BJW)

Department of Medicine and Radiology, University of Ottawa, Ottawa, Canada.

Edoardo Conte (E)

Centro Cardiologico Monzino, Institute for Research Hospitalization, and Health Care, Milan, Italy.

Ricardo C Cury (RC)

Department of Radiology, Miami Cardiac and Vascular Institute, Miami, Florida.

Gudruf Feuchtner (G)

Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.

Martin Hadamitzky (M)

Department of Radiology and Nuclear Medicine, German Heart Center Munich, Munich, Germany.

Yong-Jin Kim (YJ)

Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

Sang-Eun Lee (SE)

Division of Cardiology, Severance Cardiovascular Hospital and Severance Biomedical Science Institute, Yonsei University Health System, Yonsei University College of Medicine, Seoul, South Korea; Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University Health System, Yonsei University College of Medicine, South Korea.

Jonathon A Leipsic (JA)

Department of Medicine and Radiology, University of British Columbia, Vancouver, Canada.

Erica Maffei (E)

Department of Radiology, ASUR Marche Area Vasta 1, Urbino, Italy.

Hugo Marques (H)

Cardiovascular Imaging Unit, Unit of Cardiovascular Imaging, Hospital da Luz, Lisbon, Portugal.

Fabian Plank (F)

Department of Radiology, Innsbruck Medical University, Innsbruck, Austria.

Gianluca Pontone (G)

Centro Cardiologico Monzino, Institute for Research Hospitalization, and Health Care, Milan, Italy.

Gilbert L Raff (GL)

Department of Cardiology, William Beaumont Hospital, Royal Oak, Michigan.

Todd C Villines (TC)

Division of Cardiovascular Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia.

Harald G Weirich (HG)

Department of Radiology, Innsbruck Medical University, Innsbruck, Austria.

Iksung Cho (I)

Division of Cardiology, Severance Cardiovascular Hospital and Severance Biomedical Science Institute, Yonsei University Health System, Yonsei University College of Medicine, Seoul, South Korea; Department of Cardiology, Chung-Ang University Hospital, Seoul, South Korea.

Ibrahim Danad (I)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

Donghee Han (D)

Integrative Cardiovascular Imaging Research Center, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Ran Heo (R)

Division of Cardiology, Department of Internal Medicine, Hanyang University Medical Center, Seoul, Korea.

Ji Hyun Lee (JH)

Integrative Cardiovascular Imaging Research Center, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea; Department of Cardiology, Myongji Hospital, Goyang, South Korea.

Asim Rizvi (A)

Department of Radiology, Mayo Clinic, Rochester, Minnesota.

Wijnand J Stuijfzand (WJ)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Heidi Gransar (H)

Department of Imaging, Cedars Sinai Medical Center, Los Angeles, California.

Yao Lu (Y)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Ji Min Sung (JM)

Integrative Cardiovascular Imaging Research Center, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Hyung-Bok Park (HB)

Integrative Cardiovascular Imaging Research Center, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Daniel S Berman (DS)

Department of Imaging and Medicine, Cedars Sinai Medical Center, Los Angeles, California.

Matthew J Budoff (MJ)

Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California.

Habib Samady (H)

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.

Peter H Stone (PH)

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Renu Virmani (R)

CVPath Institute, Gaithersburg, Maryland.

Jagat Narula (J)

Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York.

Hyuk-Jae Chang (HJ)

Division of Cardiology, Severance Cardiovascular Hospital and Severance Biomedical Science Institute, Yonsei University Health System, Yonsei University College of Medicine, Seoul, South Korea.

Fay Y Lin (FY)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Lohendran Baskaran (L)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York; Department of Cardiovascular Medicine, National Heart Centre, Singapore.

Leslee J Shaw (LJ)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

James K Min (JK)

Cleerly Health, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH